| Name |
Pefloxacin (USAN/INN);PFLX |
| Formula |
C17H20FN3O3 |
| Exact mass |
333.1489 |
| Mol weight |
333.36 |
| Structure |
 |
| Simcomp |
|
| Class |
Antibacterial DG01550 Quinolone DG01549 Fluoroquinolone |
| Remark |
ATC code: J01MA03Chemical structure group: DG00618 |
| Efficacy |
Antibacterial, Nucleic acid biosynthesis inhibitor |
| Target |
DNA gyrase [KO:K02469 K02470]topoisomerase IV [KO:K02621 K02622] |
| Interaction |
|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303] J ANTIINFECTIVES FOR SYSTEMIC USE J01 ANTIBACTERIALS FOR SYSTEMIC USE J01M QUINOLONE ANTIBACTERIALS J01MA Fluoroquinolones J01MA03 Pefloxacin D02306 Pefloxacin (USAN/INN)Drug groups [BR:br08330] Antibacterial DG01550 Quinolone DG01549 Fluoroquinolone DG00618 Pefloxacin D02306 PefloxacinAntimicrobials [BR:br08307] Antibacterials Nucleic acid synthesis inhibitor Fluoroquinolone D02306 Pefloxacin (USAN/INN)Drug groups [BR:br08330] Antibacterial DG01550 Quinolone DG01549 Fluoroquinolone DG00618 Pefloxacin |
| Other DBs |
CAS: 70458-92-3PubChem: 7849365ChEBI: 50199LigandBox: D02306NIKKAJI: J283.181C |
| LinkDB |
|
| KCF data |
ATOM 24 1 C8y C 23.3537 -16.5170 2 C8y C 23.3537 -15.1174 3 C8x C 22.1406 -14.4175 4 C8y C 20.9276 -15.1174 5 C8y C 20.9276 -16.5170 6 C8x C 22.1406 -17.2169 7 N4y N 24.5658 -17.2169 8 C8x C 25.7779 -16.5170 9 C8y C 25.7779 -15.1174 10 C8y C 24.5658 -14.4175 11 O5x O 24.5658 -13.0178 12 C6a C 26.9915 -14.4167 13 O6a O 28.2050 -15.1174 14 O6a O 26.9915 -13.0178 15 X F 19.7155 -14.4173 16 N1y N 19.7155 -17.2171 17 C1x C 18.5024 -16.5169 18 C1x C 17.2904 -17.2170 19 N1y N 17.2906 -18.6167 20 C1x C 18.5037 -19.3168 21 C1x C 19.7157 -18.6168 22 C1a C 16.0770 -19.3176 23 C1b C 24.5658 -18.6166 24 C1a C 23.3543 -19.3160BOND 26 1 1 2 2 2 2 3 1 3 3 4 2 4 4 5 1 5 5 6 2 6 1 6 1 7 1 7 1 8 7 8 1 9 8 9 2 10 9 10 1 11 2 10 1 12 10 11 2 13 9 12 1 14 12 13 1 15 12 14 2 16 4 15 1 17 5 16 1 18 16 17 1 19 17 18 1 20 18 19 1 21 19 20 1 22 20 21 1 23 16 21 1 24 19 22 1 25 7 23 1 26 23 24 1 |
